NOMURA HOLDINGS INC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.

Quarter-by-quarter ownership
NOMURA HOLDINGS INC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$17,948,748
-7.2%
503,330
-33.9%
0.05%
-21.0%
Q1 2023$19,333,134
+73404.4%
761,147
+17.2%
0.06%
-42.6%
Q4 2022$26,302
-94.9%
649,548
+4031.7%
0.11%
+5300.0%
Q3 2022$520,000
-96.6%
15,721
-96.3%
0.00%
-92.3%
Q2 2022$15,316,000
+2103.7%
425,842
+2915.5%
0.03%
+1200.0%
Q1 2022$695,000
-93.2%
14,122
-90.8%
0.00%
-92.3%
Q4 2021$10,244,000
+17.3%
154,298
+10.5%
0.03%
+18.2%
Q3 2021$8,730,000
-40.3%
139,628
-20.7%
0.02%
-40.5%
Q2 2021$14,611,000
+326.5%
176,050
+241.3%
0.04%
+362.5%
Q1 2021$3,426,000
-82.0%
51,588
-79.3%
0.01%
-75.0%
Q4 2020$19,075,000
+4854.5%
248,657
+2678.3%
0.03%
+3100.0%
Q3 2020$385,000
-32.2%
8,950
-32.2%
0.00%
-50.0%
Q2 2020$568,000
-65.3%
13,200
-76.8%
0.00%
-71.4%
Q1 2020$1,637,00057,0000.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders